Literature DB >> 17395650

Treatment of hyponatraemia by urea decreases risks of brain complications in rats. Brain osmolyte contents analysis.

Alain Soupart1, Barbara Schroëder, Guy Decaux.   

Abstract

BACKGROUND: Brain damage (myelinolysis) develops in hyponatraemia after a large increase in serum sodium regardless of the currently available methods of correction. However, a preliminary study suggests that treatment of hyponatraemia with urea limits the risks of brain lesions in rats. Benefits of sustained high blood levels of urea and mechanisms of protection remain hypothetical.
METHODS: In the first part of the study, hyponatraemic rats received repeated (i.p.) doses of urea (2 g/kg b.w./6 h) leading to sustained blood levels (urea+/-230 mg/dl). Neurologic outcome was compared to correction of hyponatraemia by water diuresis. In the second part of the study, we analysed the adaptative response of the brain to correction of hyponatraemia with either urea or water diuresis, by measurement of cerebral osmolyte contents.
RESULTS: Despite a large correction of the serum sodium (mean Delta SNa=32 mEq/l/24 h), mortality rate (13%) and neurological symptoms were low in the urea-treated group contrary to control groups treated by water diuresis (mortality: 87%). This shows with stronger evidence the protective effect of urea against brain myelinolysis. In the second part, analysis of brain composition shows that, in the urea groups, 24 h after correction, intracerebral hyperionization (NaCl) was avoided and brain water contents remained normal. No significant changes of the major brain organic osmolyte composition were observed after urea administration except reaccumulation of betaine. No difference in brain composition was noted regarding concomitant plasma urea levels (>or<150 mg/dl). In rats treated by water diuresis, the brain remained also significantly depleted in organic osmolytes 24 h after correction, but contrary to administration of urea, this treatment was associated with a high mortality rate.
CONCLUSIONS: These comparative results suggest a specific brain-protective effect of urea itself against myelinolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395650     DOI: 10.1093/ndt/gfm138

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

Review 1.  Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.

Authors:  Justin L Grodin
Journal:  Curr Heart Fail Rep       Date:  2016-08

2.  [Supplement to continuing medical education article "Dysnatremia in intensive care patients"].

Authors:  M Lichtwarck-Aschoff; A Pippi; B Dietrich
Journal:  Anaesthesist       Date:  2011-04       Impact factor: 1.041

Review 3.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

Review 4.  Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Authors:  A Peri; N Pirozzi; G Parenti; F Festuccia; P Menè
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

5.  Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination after Hyponatremia Treatment.

Authors:  Fabrice Gankam-Kengne; Bruno S Couturier; Alain Soupart; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2017-01-25       Impact factor: 10.121

6.  Tuberculous lymphadenitis and syndrome of inappropriate antidiuresis, improbable partners.

Authors:  Helena Vitorino; Andrea Castanheira; Manuela Zita Veiga; Alberto Mello Silva
Journal:  BMJ Case Rep       Date:  2015-04-24

7.  Current and future treatment options in SIADH.

Authors:  Robert Zietse; Nils van der Lubbe; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11

8.  Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: a single-center experience.

Authors:  Charalampos Pierrakos; Fabio Silvio Taccone; Guy Decaux; Jean-Louis Vincent; Serge Brimioulle
Journal:  Ann Intensive Care       Date:  2012-05-30       Impact factor: 6.925

9.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

10.  Neurosurgical Hyponatremia.

Authors:  Mark J Hannon; Christopher J Thompson
Journal:  J Clin Med       Date:  2014-10-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.